{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:57:37Z","timestamp":1787003857091,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T00:00:00Z","timestamp":1196985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/sj.eye.6703061","type":"journal-article","created":{"date-parts":[[2007,12,7]],"date-time":"2007-12-07T05:59:30Z","timestamp":1197007170000},"page":"989-993","source":"Crossref","is-referenced-by-count":25,"title":["Homocysteine, folates, and the eye"],"prefix":"10.1038","volume":"22","author":[{"given":"A D","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P M","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,7]]},"reference":[{"key":"BF6703061_CR1","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS . Vascular pathology of homocysteinuria: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111\u2013128.","journal-title":"Am J Pathol"},{"key":"BF6703061_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK . Homocysteine and cardiovascular disease; evidence of causality from a meta-analysis. BMJ 2002; 325: 1202\u20131206.","journal-title":"BMJ"},{"key":"BF6703061_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cll.2006.06.008","volume":"26","author":"BA Maron","year":"2006","unstructured":"Maron BA, Loscalzo J . Homocysteine. Clin Lab Med 2006; 26: 591\u2013609.","journal-title":"Clin Lab Med"},{"key":"BF6703061_CR4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinchem\/45.1.150","volume":"45","author":"SC Martin","year":"1999","unstructured":"Martin SC, Tsakas-Ampatzia I, Bartlett WA, Jones AF . Measurement of plasma homocysteine by HPLC with coulometric detection. Clin Chem 1999; 45: 150\u2013152.","journal-title":"Clin Chem"},{"key":"BF6703061_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2006.06.025","volume":"375","author":"B Zappacosta","year":"2007","unstructured":"Zappacosta B, Persichilli S, Minucci A, Scribano D, Antenucci M, Fasanella S et al. Analytical evaluation of a new immunononephelmetric method for homocysteine measurement. Clin Chim Acta 2007; 375: 165\u2013168.","journal-title":"Clin Chim Acta"},{"key":"BF6703061_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","volume":"136","author":"MT Cahill","year":"2003","unstructured":"Cahill MT, Stinett SS, Fekrat S . A meta-analysis of plasma homocysteine, serum folate, serum B12 and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003; 136: 1136\u20131150.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/eye.2000.148","volume":"14","author":"SC Martin","year":"2000","unstructured":"Martin SC, Rauz S, Marr JE, Martin N, Jones AF, Dodson PM . Plasma total homocysteine and retinal vascular disease. Eye 2000; 14: 590\u2013593.","journal-title":"Eye"},{"key":"BF6703061_CR8","first-page":"393","volume":"37","author":"ACO Fong","year":"1993","unstructured":"Fong ACO, Schatz H . Central retinal vein occlusion in young adults. J Ophthalmol 1993; 37: 393\u2013417.","journal-title":"J Ophthalmol"},{"key":"BF6703061_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ajo.2004.06.084","volume":"139","author":"B Chua","year":"2005","unstructured":"Chua B, Kifley A, Wong TY, Mitchell P . Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 2005; 139: 181\u2013182.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(14)70001-7","volume":"117","author":"SS Hayreh","year":"1994","unstructured":"Hayreh SS, Zimmerman MB, Podhaisky P . Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429\u2013441.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR11","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","volume":"46","author":"HC Looker","year":"2003","unstructured":"Looker HC, Fagot CA, Gunter EW, Pfeiffer CM, Narayan KMV, Knowler WC et al. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 2003; 46: 766\u2013772.","journal-title":"Diabetologia"},{"key":"BF6703061_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0140-6736(05)62327-6","volume":"349","author":"O Vaccaro","year":"1997","unstructured":"Vaccaro O, Ingrosso D, Rivellese A, Greco G, Riccardi G . Moderate hyperhomocysteinemia and retinopathy in insulin-dependent diabetes. Lancet 1997; 349: 1102\u20131103.","journal-title":"Lancet"},{"key":"BF6703061_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.eye.6700702","volume":"18","author":"M Goldstein","year":"2004","unstructured":"Goldstein M, Leibovitch I, Yeffimov I, Gavendo S, Sela BA, Loewenstein A . Hyperhomocysteinemia in patients with diabetes mellitus with and without retinopathy. Eye 2004; 18: 460\u2013465.","journal-title":"Eye"},{"key":"BF6703061_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cca.2005.10.025","volume":"366","author":"EJ Huang","year":"2006","unstructured":"Huang EJ, Khu WW, Chen YJ, Chen TH, Chang M, Lu MC et al. Homocysteine and other biochemical parameters in Type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta 2006; 366: 293\u2013298.","journal-title":"Clin Chim Acta"},{"key":"BF6703061_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10792-004-6740-8","volume":"25","author":"I Yuecel","year":"2004","unstructured":"Yuecel I, Yeucel G, Mueftueoglu F . Plasma homocysteine levels in noninsulin-dependent diabetes mellitus with retinopathy and neovascular glaucoma. Int Ophthalmol 2004; 25: 201\u2013205.","journal-title":"Int Ophthalmol"},{"key":"BF6703061_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2796.2005.01560.x","volume":"258","author":"MSS Soedamah","year":"2005","unstructured":"Soedamah MSS, Chaturvedi N, Teerlink T, Idzior WR, Fuller JH, Stehouwer CDA . Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case control study. J Intern Med 2005; 258: 450\u2013459.","journal-title":"J Intern Med"},{"key":"BF6703061_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9394(03)00077-1","volume":"136","author":"RM Vessani","year":"2003","unstructured":"Vessani RM, Ritch R, Liebmann JM, Jofe M . Plasma homocysteine is elevated in patients with exfoliation syndrome. Am J Ophthalmol 2003; 136: 41\u201346.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00061198-200302000-00007","volume":"12","author":"I Leibevitch","year":"2003","unstructured":"Leibevitch I, Kurtz S, Shemesh S, Goldstein M, Sela BA, Lazar M et al. Hyperhomocysteinemia in psuedoexfoliation glaucoma. J Glaucoma 2003; 12: 36\u201339.","journal-title":"J Glaucoma"},{"key":"BF6703061_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ajo.2003.09.041","volume":"137","author":"G Wang","year":"2004","unstructured":"Wang G, Medeiros F, Barshop BA, Weinreb RN . Total plasma homocysteine and primary open-angle glaucoma. Am J Ophthalmol 2004; 137: 401\u2013406.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.eye.6701853","volume":"20","author":"K Coral","year":"2006","unstructured":"Coral K, Raman R, Rathi S, Rajesh M, Sulochana KN, Angayarkanni N et al. Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration age-related macular degeneration. Eye 2006; 20: 203\u2013207.","journal-title":"Eye"},{"key":"BF6703061_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0002-9394(03)00864-X","volume":"137","author":"R Axer-Siegel","year":"2004","unstructured":"Axer-Siegel R, Bourla D, Ehrlich R, Dotan G, Benjamin Y, Gavendo S et al. Association of neovascular age-related macular degeneration and homocysteinemia. Am J Ophthalmol 2004; 137: 84\u201389.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00417-005-0108-2","volume":"24","author":"G Kamburoglu","year":"2006","unstructured":"Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B . Plasma homocusteine, vitamin B12 and folate levels in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2006; 24: 565\u2013569.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF6703061_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archopht.119.7.1009","volume":"119","author":"PF Jacques","year":"2001","unstructured":"Jacques PF, Chylack LT, Hankinson SE, Khu PM, Rogers G, Friend J et al. Long-term nutrient intake and early age-related nuclear lens opacities. Arch Ophthalmol 2001; 119: 1009\u20131019.","journal-title":"Arch Ophthalmol"},{"key":"BF6703061_CR24","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"The Homocysteine Studies Collaboration","year":"2002","unstructured":"The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002; 288: 2015\u20132022.","journal-title":"J Am Med Assoc"},{"key":"BF6703061_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","volume":"326","author":"NJ Wald","year":"2003","unstructured":"Wald NJ, Law M . A strategy to reduce to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.","journal-title":"BMJ"},{"key":"BF6703061_CR26","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1056\/NEJMe068060","volume":"354","author":"J Loscalzo","year":"2006","unstructured":"Loscalzo J . Homocysteine trials\u2014clear outcomes for complex reasons. N Engl J Med 2006; 354: 1629\u20131632.","journal-title":"N Engl J Med"},{"key":"BF6703061_CR27","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1001\/jama.296.22.2720","volume":"296","author":"LA Bazzano","year":"2006","unstructured":"Bazzano LA, Reynolds K, Holder KN, He J . Effect of folic acid supplementation on risk of cardiovascular diseases. A meta-analysis of randomized controlled trials. J Am Med Assoc 2006; 296: 2720\u20132726.","journal-title":"J Am Med Assoc"},{"key":"BF6703061_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2362.2006.01639.x","volume":"26","author":"GH Schernthaner","year":"2006","unstructured":"Schernthaner GH, Plank C, Minar E, Biegimayer C, Koppensteiner R, Schernthaner G . No effect of homocysteine-lowering therapy on vascular inflammation and maemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 2006; 26: 333\u2013339.","journal-title":"Eur J Clin Invest"},{"key":"BF6703061_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-146-11-200706050-00157","volume":"146","author":"JG Ray","year":"2007","unstructured":"Ray JG, Kearon C, Yi Q, Sheridan P, Lonn E . Homocysteine lowering therapy and risk for venous thromboembolism: a randomized trial. Ann Int Med 2007; 146: 761\u2013767.","journal-title":"Ann Int Med"},{"key":"BF6703061_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0002-9394(01)00922-9","volume":"132","author":"M Kuzniarz","year":"2001","unstructured":"Kuzniarz M, Mitchell P, Cumming RG, Flood VM . Use of vitamin supplements and cataract: the blue mountain eye study. Am J Ophthalmol 2001; 132: 19\u201326.","journal-title":"Am J Ophthalmol"},{"key":"BF6703061_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(07)60109-3","volume":"369","author":"J Durga","year":"2007","unstructured":"Durga J, van Boxtel MP, Schouten EG, Kok FJ, Jolles J, Katan MB et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007; 369: 208\u2013216.","journal-title":"Lancet"},{"key":"BF6703061_CR32","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1016\/S0140-6736(07)60854-X","volume":"369","author":"X Wang","year":"2007","unstructured":"Wang X, Qin X, Demirtas H, Li J, Mao G, Huo G et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369: 1876\u20131882.","journal-title":"Lancet"},{"key":"BF6703061_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1056\/NEJMoa067103","volume":"357","author":"P de Wals","year":"2007","unstructured":"de Wals P, Tairou F, van Allen MI, Uh SH, Lowry RB, Sibbald B et al. Reduction in neural tube defects after folic acid fortification in Canada. N Engl J Med 2007; 357: 135\u2013142.","journal-title":"N Engl J Med"},{"key":"BF6703061_CR34","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/S0140-6736(06)68582-6","volume":"367","author":"M Eichholzer","year":"2006","unstructured":"Eichholzer M, Tonz O, Zimmermann R . Folic acid: a public health challenge. Lancet 2006; 367: 1352\u20131361.","journal-title":"Lancet"},{"key":"BF6703061_CR35","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1136\/bmj.39232.493252.47","volume":"334","author":"NJ Wald","year":"2007","unstructured":"Wald NJ, Oakley GP, Hubner RA, Houlston RD, Muir KR . Should folic acid fortification be mandatory? BMJ 2007; 334: 1252\u20131253.","journal-title":"BMJ"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6703061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703061","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6703061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:31:54Z","timestamp":1684398714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6703061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,7]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BF6703061"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6703061","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,7]]}}}